The Effect of PinnoThin on Satiety and Food Intake

Not Applicable

Completed

• Conditions: Obesity
• Interventions: Dietary Supplement: PinnoThin

• Registration Number: NCT01034605
• Lead Sponsor: Maastricht University Medical Center

Brief Summary

Based upon an increased secretion of gastrointestinal satiety hormones (CCK, GLP-1), PinnoThin is hypothesized to be more satiating, and to limit energy intake in humans. Therefore, the objective of this study is to investigate whether PinnoThin leads to an increase in satiety as determined by VAS ratings? Additionally, does PinnoThin consumed during breakfast, in comparison to placebo, in overweight women, lead to a decrease in energy intake during an ad libitum lunch?

Detailed Description

Not available

Study Timeline

• Study Start: 2008-12
• Study First Submitted: 2009-12-02
• Study First Submitted QC: 2009-12-16
• Study First Posted: 2009-12-17
• Primary Completion: 2010-01
• Study Completion: 2010-01
• Status Verified: 2012-08
• Last Update Submitted: 2012-08-29
• Last Update Posted: 2012-08-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 40

Inclusion Criteria

• age over 18 and under 45
• women
• BMI over 23 and under 30
• breakfast eaters

Exclusion Criteria

• men
• age under 18 and over 45
• BMI under 23 and over 30
• use of medication
• pregnant and breastfeeding

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Arm && Interventions

Group	Intervention	Description
inulin	PinnoThin	oligofructose

Primary Outcome Measures

Name	Time	Method
appetite profile ratings	10 timepoints

Secondary Outcome Measures

Name	Time	Method
energy intake	3.5 hours after PinnoThin

Trial Locations

Locations (1)

Maastricht University; 🇳🇱 Maastricht, Limburg, Netherlands